nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Oral pain—Sorafenib—thyroid cancer	0.115	0.115	CcSEcCtD
Phentolamine—Oral pain—Epirubicin—thyroid cancer	0.0424	0.0424	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—thyroid cancer	0.0392	0.0392	CcSEcCtD
Phentolamine—Blood pressure increased—Sorafenib—thyroid cancer	0.0299	0.0299	CcSEcCtD
Phentolamine—Bradycardia—Vandetanib—thyroid cancer	0.0227	0.0227	CcSEcCtD
Phentolamine—Cardiac disorder—Vandetanib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Phentolamine—Angiopathy—Vandetanib—thyroid cancer	0.0202	0.0202	CcSEcCtD
Phentolamine—Mediastinal disorder—Vandetanib—thyroid cancer	0.0201	0.0201	CcSEcCtD
Phentolamine—Arrhythmia—Vandetanib—thyroid cancer	0.0199	0.0199	CcSEcCtD
Phentolamine—Abdominal pain upper—Sorafenib—thyroid cancer	0.0198	0.0198	CcSEcCtD
Phentolamine—Hypertension—Vandetanib—thyroid cancer	0.0167	0.0167	CcSEcCtD
Phentolamine—Chest pain—Vandetanib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Phentolamine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.0165	0.0165	CcSEcCtD
Phentolamine—Myocardial infarction—Sorafenib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Phentolamine—Nervous system disorder—Vandetanib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Phentolamine—Paraesthesia—Vandetanib—thyroid cancer	0.0142	0.0142	CcSEcCtD
Phentolamine—Cardiac disorder—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Phentolamine—Flushing—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Phentolamine—Angiopathy—Sorafenib—thyroid cancer	0.0136	0.0136	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—thyroid cancer	0.0135	0.0135	CcSEcCtD
Phentolamine—Mediastinal disorder—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Phentolamine—Pain—Vandetanib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Phentolamine—Arrhythmia—Sorafenib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Phentolamine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—thyroid cancer	0.0125	0.0125	CcSEcCtD
Phentolamine—Abdominal pain—Vandetanib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Phentolamine—Asthenia—Vandetanib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Phentolamine—Hypertension—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Phentolamine—Pruritus—Vandetanib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—thyroid cancer	0.011	0.011	CcSEcCtD
Phentolamine—Diarrhoea—Vandetanib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Phentolamine—Nervous system disorder—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Phentolamine—Dizziness—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—thyroid cancer	0.0102	0.0102	CcSEcCtD
Phentolamine—Vomiting—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Phentolamine—Headache—Vandetanib—thyroid cancer	0.00992	0.00992	CcSEcCtD
Phentolamine—Nausea—Vandetanib—thyroid cancer	0.0094	0.0094	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00922	0.00922	CcSEcCtD
Phentolamine—Pain—Sorafenib—thyroid cancer	0.00913	0.00913	CcSEcCtD
Phentolamine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00873	0.00873	CcSEcCtD
Phentolamine—Abdominal pain—Sorafenib—thyroid cancer	0.00844	0.00844	CcSEcCtD
Phentolamine—Asthenia—Sorafenib—thyroid cancer	0.00766	0.00766	CcSEcCtD
Phentolamine—Pruritus—Sorafenib—thyroid cancer	0.00756	0.00756	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00733	0.00733	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—thyroid cancer	0.00733	0.00733	CcSEcCtD
Phentolamine—Diarrhoea—Sorafenib—thyroid cancer	0.00731	0.00731	CcSEcCtD
Phentolamine—Dizziness—Sorafenib—thyroid cancer	0.00706	0.00706	CcSEcCtD
Phentolamine—Vomiting—Sorafenib—thyroid cancer	0.00679	0.00679	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—thyroid cancer	0.00676	0.00676	CcSEcCtD
Phentolamine—Headache—Sorafenib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Phentolamine—Nausea—Sorafenib—thyroid cancer	0.00634	0.00634	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—thyroid cancer	0.00626	0.00626	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—thyroid cancer	0.00566	0.00566	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—thyroid cancer	0.00523	0.00523	CcSEcCtD
Phentolamine—Flushing—Epirubicin—thyroid cancer	0.00516	0.00516	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—thyroid cancer	0.00516	0.00516	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—thyroid cancer	0.00504	0.00504	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00501	0.00501	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—thyroid cancer	0.00466	0.00466	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00463	0.00463	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—thyroid cancer	0.00418	0.00418	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—thyroid cancer	0.00385	0.00385	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—thyroid cancer	0.00369	0.00369	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—thyroid cancer	0.00356	0.00356	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Phentolamine—Pain—Epirubicin—thyroid cancer	0.00338	0.00338	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Phentolamine—Pain—Doxorubicin—thyroid cancer	0.00312	0.00312	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—thyroid cancer	0.00312	0.00312	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—thyroid cancer	0.0027	0.0027	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Phentolamine—Headache—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Phentolamine—Nausea—Epirubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Phentolamine—Headache—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
